Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice. (2023)

First Author: Chen D

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1227133

PubMed Identifier: 37731505

Publication URI: http://europepmc.org/abstract/MED/37731505

Type: Journal Article/Review

Volume: 14

Parent Publication: Frontiers in immunology

ISSN: 1664-3224